Načítá se...
Pharmacokinetics of Single Oral Dose Extended‐Release Levetiracetam in Healthy Cats
BACKGROUND: Repeated PO dosing of anti‐epileptic drugs may contribute to poor compliance in treated cats. Intermediate‐release levetiracetam has been used safely in cats, but must be given q8h to maintain serum concentrations in the therapeutic interval for humans (5–45 μg/mL). Approved extended‐rel...
Uloženo v:
| Vydáno v: | J Vet Intern Med |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5787171/ https://ncbi.nlm.nih.gov/pubmed/29114943 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jvim.14863 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|